Pharmafile Logo

Patient Recruitment: Think Global, Act Local

Global clinical trials are a vital component of pharma R&D. Utilizing sites in multiple countries not only provides increased access to eligible and diverse patients – and therefore more robust data – but also promotes health equity and research and innovation across continents.Another benefit of global clinical trials is the potential for these studies to be completed more quickly and efficiently [1]. However, around four in five clinical trials fail to meet their patient recruitment deadlines [2], which delays patient access to innovative new therapeutics and can prove costly to Sponsors.Just as treatments are becoming more personalized, so should clinical trial patient recruitment strategies. A ‘one size fits all’ approach to enrollment fails to consider how factors such as an individual country’s culture, healthcare structure and patients’ needs can affect a site’s ability to recruit eligible participants. The key to patient enrollment success is to ‘think local’, even for global studies.In this webinar, we will:Discuss the benefits of using a diversified patient recruitment approach for each country within a global studyInvestigate how patient recruitment strategies can differ from country to country,Hear from two in-country patient recruitment specialists about the challenges relevant to their regions and how they work with sites to overcome theseShare how Innovative Trials’ ‘boots-on-the-ground’ approach in more than 70 countries around the world can help accelerate patient recruitment and retention for your clinical trials.SpeakersGeorgia Hardy – Site Operations Lead, Innovative TrialsNicole Yingst – Associate Director, Patient Recruitment Programs, PfizerBarbara OrlosKaminska – Clinical Enrollment Manager (Poland), Innovative Trials


This content was provided by Innovative Trials

Company Details

 Latest Content from  Innovative Trials 

Seven strategic steps to enhance patient recruitment & retention in your influenza studies

The development of all treatments, including vaccines, is dependent on people taking part in clinical trials but this can be challenging for influenza studies, especially given the typically short patient...

Innovative Trials celebrates success for its groundbreaking Retention Patch Program

Innovative Trials attended the PME Award Gala Dinner last night (21st November 2024)

Movember 2024 – Men’s Health

This Movember, Innovative Trials are raising awareness about men’s health issues like prostate cancer, testicular cancer, and mental health.

Is your influenza clinical trial prepared for the upcoming flu season? Part 3

This blog will discuss some important aspects to consider to maximise patient retention on your flu clinical trials. For more information on patient recruitment considerations, check out our previous blogs...

Is your influenza clinical trial prepared for the upcoming flu season? Part 2

Around 86% of clinical trials do not meet patient recruitment goals, ultimately failing to improve patient outcomes and resulting in financial losses for sponsors and research sites (Rangu and Maxwell,...

Is your influenza clinical trial prepared for the upcoming flu season? Part 1

The Northern Hemisphere flu season is fast approaching, bringing with it a multitude of challenges for respiratory clinical trials. The exact dates of the flu season in the Northern Hemisphere...

How Innovative Trials are making a difference to clinical trials in the US

Eloise Moffett, Innovative Trials’ Vice President of Commercial, reflects on how the company’s growing presence in the US is transforming client relationships and its ability to provide the best patient-centric...

Innovative Trials named a top UK women-powered company in clinical research by J.P. Morgan

Innovative Trials has been named the second-fastest-growing, women-powered UK company in clinical research and ranks among the top 200 women-powered businesses in the UK!

Innovative Trials named a finalist at the PME Award

Patient recruitment and retention company, Innovative Trials, was shortlisted as a finalist in the PME Award for its collaboration with US non-profit Oliver Patch Project to improve patient outcomes.

Innovative Trials appoints new Leadership Team member

Patient Recruitment company, Innovative Trials, appointed new Finance and Business Services Director